Ameriprise’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-220,630
| Closed | -$3.96M | – | 3782 |
|
|
2017
Q4 | $3.96M | Buy |
220,630
+7,384
| +3% | +$90.9K | ﹤0.01% | 2290 |
|
|
2017
Q3 | $2.52M | Buy |
213,246
+81,456
| +62% | +$914K | ﹤0.01% | 2488 |
|
|
2017
Q2 | $1.38M | Buy |
131,790
+1,690
| +1% | +$17.2K | ﹤0.01% | 2785 |
|
|
2017
Q1 | $1.43M | Buy |
+130,100
| New | +$1.51M | ﹤0.01% | 2723 |
|
|
2016
Q2 | – | Sell |
-505,854
| Closed | -$5.53M | – | 3882 |
|
|
2016
Q1 | $5.53M | Buy |
505,854
+85,199
| +20% | +$1.08M | ﹤0.01% | 1879 |
|
|
2015
Q4 | $7.27M | Buy |
420,655
+345,823
| +462% | +$6.2M | ﹤0.01% | 1707 |
|
|
2015
Q3 | $1.49M | Buy |
+74,832
| New | +$1.72M | ﹤0.01% | 2783 |
|
|
2015
Q2 | – | Sell |
-72,204
| Closed | -$1.12M | – | 4114 |
|
|
2015
Q1 | $1.12M | Buy |
+72,204
| New | +$1.12M | ﹤0.01% | 2884 |
|
|
2014
Q4 | – | Sell |
-1,730
| Closed | -$11K | – | 4853 |
|
|
2014
Q3 | $11K | Hold |
1,730
| – | – | ﹤0.01% | 4802 |
|
|
2014
Q2 | $12K | Hold |
1,730
| – | – | ﹤0.01% | 4595 |
|
|
2014
Q1 | $12K | Hold |
1,730
| – | – | ﹤0.01% | 4465 |
|
|
2013
Q4 | $16K | Sell |
1,730
-854
| -33% | -$6.09K | ﹤0.01% | 4171 |
|
|
2013
Q3 | $16K | Sell |
2,584
-10
| -0.4% | -$62 | ﹤0.01% | 4586 |
|
|
2013
Q2 | $17K | Buy |
+2,594
| New | +$20.6K | ﹤0.01% | 4407 |
|
Other funds holding SCMP
Ameriprise's SCMP Position: Q1 2018 in Review
Ameriprise sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 220,630 shares — an estimated $3.96M sold.
Ameriprise first reported a position in SCMP in Q2 2013 and held it in 14 quarters. The position peaked at $7.27M in Q4 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Ameriprise reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Ameriprise sold 220,630 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $3.96M.
- Ameriprise first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
- Ameriprise's Sucampo Pharmaceuticals, Inc. position peaked at $7.27M in Q4 2015.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Ameriprise's 13F filing for Q1 2018, filed 15 May 2018.